Objective: This study was aimed to develop a tool for the standardized assessment of patient-reported outcomes (PROs) to assist the choice of instruments. Methods: An expert panel adapted the eight attributes proposed by the Medical Outcomes Trust as evaluation review criteria, created items to evaluate them, and included a response scale for each item. A pilot test was designed to test the new tool's feasibility and to obtain preliminary information concerning its psychometric properties. The Spanish versions of five measures were selected for assessment: the SF-36 Health Survey, the Nottingham Health Profile, the COOP-WONCA charts, the EuroQol-5D, and the Quality of Life Questionnaire EORTC-QLQ-C30. We assessed the new tool's reliability (Cronbach's alpha and intraclass correlation coefficient [ICC]) and construct validity.
Introduction
The search for health outcome measures that incorporate the patient's perspective has led to the production of an increasing number of "patient-reported outcome" (PRO) measures [1, 2] . This has been in part due to new models of care with greater patient involvement in decision-making, as well as the recognition that these measures can independently predict the use of health services, such as hospitalization, primary care, health-care needs, and even mortality [3, 4] . They also elicit information which has found to be complementary to commonly used clinical measures [5] . Recent estimates, based solely on publications in English, place the number of measures at 1275 [6] . This poses at least two problems: 1) how to identify questionnaires which are available for a specific use (e.g., a study of functional status in patients with asthma); and 2) how to choose the most appropriate measure from among those available. Some initiatives have addressed the first of these problems by compiling catalogues of questionnaires in different formats (including books and electronic databases) [7] [8] [9] [10] [11] [12] .
As regards the second question, criteria are needed to identify the strengths and weaknesses of the PRO measures. These criteria should cover the conceptual and theoretical model on which the measure is based, as well as its psychometric properties (reliability, validity, or sensitivity to change). Several attempts have been made to systemize review criteria for PRO measures, all of which are inspired by the seminal work of McDowell et al. [7] . Several attempts have been made to systematize review criteria for PRO measures. The GraQol Index was the first attempt to develop a tool that generated a global score [13] . Although promising, the authors recognized several limitations in the evaluation of specific attributes and criteria selected which limited its use [13] . The majority of other initiatives have not transcended the use they were originally designed for with one possible exception, namely the proposal by the Scientific Advisory Committee of the Medical Outcomes Trust (MOT). The MOT is a nonprofit organization in the United States, which aims to provide quality control guidelines for the development of measures that incorporate the patient's perspective in the field of health service research [14] . Based initially on sound theoretical grounds, the MOT initiative was recently expanded to include an explicit guide as to how each criterion should be met [15] .
The aims of the present study were to apply these recent advances to develop a tool for the standardized assessment of PRO measures and to obtain preliminary information on its validity and reliability.
Methods
The Spanish Cooperative Investigation Network for Health and Health Service Outcomes Research (Red-IRYSS) was established in 2002 and had as one of its main goals the promotion of health-related quality of life measures for use with Spanish-speaking populations [16] . As it was considered that one way of achieving this aim would be to have a tool available for the standardized assessment of PRO measures, members of the Red IRYSS reviewed earlier initiatives to produce such a tool. After review, the updated version of the MOT proposal was selected as providing the most comprehensive and explicit set of recommendations available [15] . This proposal is the broadest in scope in terms of the attributes assessed, as it includes the psychometric characteristics of the questionnaires as well as the administration procedures; it also provides the most thorough specification of criteria that need to be met by PRO measures.
Development
As a first step in the development of the new tool, a panel of four experts was nominated, based on their substantive experience in the development, assessment, and use of PRO measures (see Acknowledgments for the members of the panel). The panel operatively defined the quality of a PRO instrument as the "degree of confidence that all possible bias has been minimized and that the information about the process which led to its development and evaluation is clear and accessible."
The content of the new tool was generated by converting each of the specific criteria in the MOT proposal into individual items. The expert panel aimed to respect the original wording as far as possible and to maximize standardization of the assessmentincorporated quantitative criteria based on the literature whenever possible [14] [15] [16] [17] [18] .
The format of the instrument (response options and structure) was based on the AGREE (Appraisal of Guidelines Research and Evaluation) instrument, a tool originally conceived for the appraisal of clinical practice guidelines [19] . This instrument has been shown to have excellent properties, and it has been widely disseminated [19] [20] [21] [22] .
The resulting tool was then circulated to other researchers for their views on the clarity of its content, comprehensiveness, and ease of use (see Acknowledgments). A final version was obtained which incorporated their suggestions, and a user's manual was produced.
Assessment Process
Once the tool was created, the expert panel defined the process to be followed when evaluating a PRO measure, consisting on the assessment by several reviewers of standardized information retrieved for each PRO measure.
Evaluation of Psychometric Properties
A pilot study was performed to test the new tool's feasibility of use and measurement properties (score distributions, reliability, and validity). The measures assessed were the Spanish versions of five well-known and widely used PRO instruments. These included four commonly used generic questionnaires [6] (the SF-36 Health Survey [23, 24] , the Nottingham Health Profile [25, 26] , the COOP-WONCA Charts [27, 28] , and the EuroQol-5D [29, 30] ), and an instrument used in patients with cancer (the Quality of Life Questionnaire EORTC-QLQ-C30 [31, 32] ).
Twenty reviewers were invited to participate based on their experience in using and evaluating PRO measures. Only one reviewer declined to participate. All but four reviewers were members of the Scientific Committee on "Patient-Reported Outcomes" of the IRYSS Network. The others were external researchers without any formal link to the project. Five panels were formed to review the selected instruments: four panels had four reviewers each and one panel had three reviewers. The four member panels each included one of the external reviewers. Each panel was assigned one of the selected instruments to assess. Within each panel, instruments were assessed independently by the reviewers; reviewers had not been involved in the development or adaptation of the instrument assigned.
In order to complete the assessment, each reviewer was provided with the new tool, together with the following documents:
• The original and Spanish versions of the instrument to be assessed; • The user manual for the Spanish version;
• Related full-text publications (articles, conference papers, information provided by the authors and other documents), which provided information concerning the adaptation into Spanish; • An article describing the conceptual model of the original questionnaire (not the Spanish version); • Publications on the validation of the Spanish version and other information related to psychometric properties; and • A list of all the references identified related to applications of the questionnaire (with summaries when available).
All these documents were identified through a systematic review performed for each questionnaire [33] . Selected databases included PubMed [34, 35] , ISI Web of Knowledge [36] , ProQOLID [37] , as well as the Iberoamerican bibliographic databases LILACS [38] and SCIELO [39] , and local databases of Spanish biomedical literature, including databases of doctoral theses [40] [41] [42] [43] . Specific search definitions for each database are available from the authors upon request. Nonelectronic sources were also searched [6, [8] [9] [10] [11] [12] 44] . All searches were performed between April and June 2004.
The documentation was made available to reviewers both on a CD-ROM and on a secure web site with password-protected access. Materials also included written instructions on the assessment procedure and reviewers were asked to complete the review within 30 days.
Analytic Strategy
In order to assess the feasibility of EMPRO, the proportion of assessments that were returned within the established time period and the number of missing values per assessment was determined. Floor and ceiling effects were calculated for each attribute as the percentage of assessments with the minimum (floor) and maximum (ceiling) scores [45] .
Reliability was assessed by examining internal consistency and reproducibility [46] . Internal consistency was calculated using Cronbach's alpha coefficient for each attribute in each panel, and a global estimate in each panel was also obtained (median). Reproducibility was measured as interrater concordance on attribute scores and was assessed using the intraclass correlation coefficient (ICC) for random effects in each panel (two-way model, absolute agreement) [47] . In order to determine whether being an external reviewer affected the assessment, we performed face-to-face comparisons for all reviewer pairs in each panel including external reviewers (ICC). For all reliability measurements, values greater than 0.7 were considered acceptable, and values greater than 0.9 were considered highly satisfactory [17] .
A priori hypotheses were formulated with regard to construct validity. We hypothesized that instrument quality would be related to the quality of the publications featuring the instrument. The rationale was that studies describing well-developed, thoroughly tested instruments would have a greater chance of being published in higher-quality publications. The quality of the related publications was defined in terms of selected bibliometric characteristics, namely: 1) absolute number of publications; and 2) citations referring to the first publication (ISI Journal Citation Reports) [48] . The time the instrument had been available (number of years elapsed since the publication of the first article) was also taken into account to determine its effect on the assessment. The Spearman correlation coefficient was used to measure the association between these variables and the attribute scores [49] . Given the small sample of measures (n = 5), emphasis was placed on direction of the associations observed rather than statistical significance. All analyses were carried out using the R software (R Foundation for Statistical Computing, Vienna, Austria) [50] .
Results

The EMPRO Tool
The new tool consisted of 39 items organized in eight attributes: Conceptual and measurement model (7 items); Reliability (8); Validity (6); Responsiveness (3); Interpretability (3); Administration burden (7); Alternative modes of administration (2); and Cross-cultural and linguistic adaptations (3) . Each item consisted of a statement together with a short text to help in its interpretation and application. Reviewers expressed their degree of agreement with the statement on an ordinal Likert-type response scale: "Strongly agree" (4), "Agree" (3), "Disagree" (2) , and "Strongly disagree" (1). Space was provided on each item for comments and references to relevant publications or documents.
At the end of the instrument, reviewers were requested to provide an overall recommendation for the measure and provide a rationale for their recommendation. Possible choices were: "Strongly recommended," "Recommended with provisos or alterations," "Would not recommend," and "Unsure."
Scores were assigned based on attribute scores, as well as on the overall degree of recommendation. Attribute scores were calculated as the mean of the responses to all items for that attribute, with a lineal transformation to obtain the scores on a scale from 0 (minimum) to 100 (maximum).
The new tool was named EMPRO (Evaluating the Measurement of Patient-Reported Outcomes). Examples of item structure and overall ratings are shown in Figures 1 and 2 , respectively. Full content is available in Appendix 1 (Supplementary material).
Pilot Test
Materials for the evaluation of selected measures. The questionnaire-specific systematic reviews identified a variable number of articles, ranging from 6 to 18. All of the articles detailing the conceptual model of the original version of the questionnaire (n = 5, one per questionnaire) and most of those reporting the adaptation into Spanish were published in international journals (median proportion of international publications = 67%, range from 20% to 80%). The number of citations for the first reference reporting the cultural adaptation ranged from 133 to 0. A user manual was identified for all of the instruments.
Feasibility. All assessments were carried out within the required time period (1 month) and there were no missing data. Nine reviewers (47.4%) completed a questionnaire on the documentation provided, and all found the documentation "Relevant" or "Very relevant" and the selection of materials "Quite appropriate" or "Very appropriate." One reviewer considered the information "Insufficient."
Attribute scores for individual reviewers ranged from 22 to 100 (median scores ranged from 25 to 100) ( Table 1) . No floor effect was therefore observed. Three attributes (Reliablity, Validity, and Responsiveness) did not receive the maximum score (100) on any of their individual items. A ceiling effect was observed for the attributes of cross-cultural and linguistic adaptations (36.8%) and Interpretability (15.8%).
Reliability and validity. As regards internal consistency, Cronbach alpha coefficients were above 0.7 for all attributes (Table 1) . Internal consistency was very high when calculated for all EMPRO items as a whole (median a = 0.95). The degree of agreement was
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similar between members of the scientific committee and external assessors and members of the scientific committee (data not shown). We also explored the effect of the availability of information on agreement (ICC): no correlation was found between the degree of concordance and the number of articles published (Spearman Rho = -0.05, P = 0.93), but a correlation was found between the degree of concordance and years elapsed since the publication of the first article about the adapted version (Spearman Rho = 0.89, P < 0.05). Positive associations consistent with our a priori hypotheses were observed between EMPRO attribute scores and the number of articles identified for each questionnaires and the number of citations ( Table 2 ). The only exceptions were correlation coefficients close to 0 between scores on the attribute of "Responsiveness" and number of articles, and between "Administrative Burden" and the number of citations. The overall recommendations also showed the expected associations. All correlations observed between years elapsed since the publication of the first article and EMPRO scores were positive.
Discussion
A new tool has been developed, based on earlier explicit recommendations, to aid in the standardized assessment of PRO measures. It has been successfully used to evaluate the Spanish versions of five wellknown PRO measures, and the results of the pilot study suggest that it is feasible to use and provide preliminary evidence of its psychometric properties.
The study had a number of limitations. First, the results are based on a small number of reviewers and instruments. Although we did not observe any substantial departure of the assumptions for the calculation of the indices and statistical tests in our study, further replication of our methods in larger samples is necessary. Second, the measures used to evaluate EMPRO's psychometric properties were Spanish versions. It is likely that the retrieval of information for the original instruments would have resulted in an increased number of publications. Nevertheless, it is possible that EMPRO's performance would improve with an increase in the amount and quality of information available for the measures assessed. Third, the assessment of the construct validity for this new tool is still tentative. The bibliometric criteria and their hypothesized associations with the scores were proxies of scientific quality, and they may therefore not represent the quality of a particular manuscript. Fourth, although we asked some researchers about their views on clarity, comprehensiveness, relevance, and ease of use of the tool, we did not perform a formal cognitive pretest before this pilot testing. Nonetheless, agreement regarding the quality of the measures assessed was high among reviewers, thereby suggesting that the items were actually understood in a similar way by the respondents.
Characteristics of the EMPRO Tool
The values obtained for internal consistency can be considered satisfactory, with all attributes reaching 0.7 and four of them (50%) with coefficients of 0.8 or higher. As reliability depends on the number of items and observations (in part), further studies should include a larger number of measures, and alternative approaches using modern test theory could be applied [51] . The observed level of interrater agreement can also be considered very satisfactory. Our data also suggest that the EMPRO tool is valid. The method used to develop the instrument supports its content validity, and as a matter of fact the MOT proposal has been very recently used in a similar initiative [52] . The expected associations were observed between EMPRO scores and the variables proposed, supporting the construct validity of the tool. Nevertheless, these relations are also consistent with the hypothesis that EMPRO scores depend on the quantity and quality of the information provided for the assessment. The correlation found between the scores and the information provided (quantity and quality) stresses the need for the information to be identified by means of standardized procedures (systematic review) and be subsequently organized according to explicit criteria.
It was not possible to evaluate the responsiveness of the new tool in the present study. This could be linked to the availability of new information concerning questionnaires that have previously been assessed, based on either new articles, conference papers, or information provided directly by the author.
Applicability
The availability of an instrument to assess the psychometric characteristics and ease of use of PRO measures entails a significant advantage for diverse fields of application, such as clinical, administrative, and research applications. The diversity of existing questionnaires and their relatively recent development make it difficult to identify the most appropriate one for a given use such as monitoring patients in clinical practice [53] , identifying population preferences, or choosing the most appropriate questionnaire to evaluate the effect of a therapeutic intervention in a clinical trial. The lack of success of previously developed assessment tools is due largely to the fact that they were developed for use within specific contexts, such as in compilations of PRO questionnaires, and therefore, with rare exceptions, have not been disseminated independently. The instrument we propose has the advantage that it has been developed based on the updated recommendations of experts and that it explicitly specifies review criteria. Researchers will also find in EMPRO a powerful tool in their practice, particularly when considering recent FDA guidance which has established an iterative PRO Instrument Development and Modification Process that explicitly recognizes the assessment of measurement properties as a key step in the refinement of the instruments [54] . Specifically, each of the four measurement properties that the FDA guidance recommend to review (reliability, validity, ability to detect change, and choice of methods for interpretation) corresponds to one of the EMPRO attributes.
Four considerations are worth making for future users of the tool. First, the EMPRO tool relies completely on information obtained in studies in which the instruments are assessed within a specific application. Second, overall ratings and attribute scores are conceptually different measures which are not intended to be interchangeable. The latter are based on the application of explicit criteria, while the overall ratings involve making a subjective recommendation for the instrument given the specific purposes (concept and populations) it was designed for. Both measures provide relevant complementary information that should be considered together when comparing ques- tionnaires. Third, given the lack of experience with this newly available tool, explicit guides to interpretation have not yet been developed. Available scores for five of the most widely used instruments might prove a useful starting point. Fourth, the choice of any measure will depend on the intended use. In this context, the assessment with EMPRO of several competing PRO questionnaires could help potential users to identify those meeting minimal criteria to be included in the selection. Furthermore, some attributes could assist the choice of the most suitable measure for a specific application. For example, information on responsiveness will be particularly relevant for longitudinal studies designed to evaluate therapeutic interventions, while administrative burden might be of particular relevance if measures are to be used in quality programs within health-care delivery systems. Finally, the application of EMPRO assumes expert knowledge in the use and assessment of PRO measures. Although it is true that the instrument includes a basic guide to the main concepts, reviewers need a minimum level of knowledge to guarantee interrater concordance. A set of training materials to prepare people who will use EMPRO is currently being developed. Moreover, given the learning curve, it is not unreasonable to expect that interrater concordance would increase if the same reviewers reassessed the same instruments using EMPRO. In the same way, the minimum amount of information needed for each instrument is difficult to establish.
Conclusions
The EMPRO is a new tool that is available to assess the measurement properties and ease of use of PRO measures. Preliminary testing supports its validity and reliability, but replication of our observations is needed, using different PRO measures and reviewers. If these promising results are confirmed, EMPRO should facilitate the selection of the most appropriate PRO measure among competing instruments. 
